http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30246533

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 7
issn 2090-0392
pageRange 196307-7
publicationName International Journal of Hypertension
startingPage 196307
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_634e3b5dadc053b60b99fda0b87acb04
bibliographicCitation Sugimoto K, Katsuya T, Kamide K, Fujisawa T, Shimaoka I, Ohishi M, Morishita R, Ogihara T, Rakugi H. Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study. International Journal of Hypertension. 2010;2010():1–7. doi: 10.4061/2010/196307.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6508-4338
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ceb02b397a23529b463d4be61e964d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fc9b100eaaa0af745e3bd2182c1e55f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_023901093996ce5cff64b4ddf7d5c576
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c89fb584ccdbeee211952e7b64dd2dc7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5d9a8a5e4930351e926650289749ac5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afe9a519a95d44fe065a4fd11d58a364
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d3348cfa85a78920e307f04be2a4ee4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf47c53ec64c8671c445cdc35455c32d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46ebb83441f61fd6009b5ac4eae8a511
date 2010-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/20981351
https://pubmed.ncbi.nlm.nih.gov/PMC2958339
https://doi.org/10.4061/2010/196307
isPartOf https://portal.issn.org/resource/ISSN/2090-0392
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38276
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a472b8907b51183da07c95de4cf028f8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65948

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129534168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128203001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129544235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129908561

Total number of triples: 45.